374 related articles for article (PubMed ID: 10843664)
21. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
22. CD8+ T cell cross-priming via transfer of proteasome substrates.
Norbury CC; Basta S; Donohue KB; Tscharke DC; Princiotta MF; Berglund P; Gibbs J; Bennink JR; Yewdell JW
Science; 2004 May; 304(5675):1318-21. PubMed ID: 15166379
[TBL] [Abstract][Full Text] [Related]
23. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.
Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW
J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.
Fenteany G; Standaert RF; Lane WS; Choi S; Corey EJ; Schreiber SL
Science; 1995 May; 268(5211):726-31. PubMed ID: 7732382
[TBL] [Abstract][Full Text] [Related]
25. The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events.
Qureshi N; Perera PY; Shen J; Zhang G; Lenschat A; Splitter G; Morrison DC; Vogel SN
J Immunol; 2003 Aug; 171(3):1515-25. PubMed ID: 12874245
[TBL] [Abstract][Full Text] [Related]
26. MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells.
Sijts AJ; Standera S; Toes RE; Ruppert T; Beekman NJ; van Veelen PA; Ossendorp FA; Melief CJ; Kloetzel PM
J Immunol; 2000 May; 164(9):4500-6. PubMed ID: 10779750
[TBL] [Abstract][Full Text] [Related]
27. The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis.
Delic J; Masdehors P; Omura S; Cosset JM; Dumont J; Binet JL; Magdelénat H
Br J Cancer; 1998 Apr; 77(7):1103-7. PubMed ID: 9569046
[TBL] [Abstract][Full Text] [Related]
28. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response.
Mimnaugh EG; Chen HY; Davie JR; Celis JE; Neckers L
Biochemistry; 1997 Nov; 36(47):14418-29. PubMed ID: 9398160
[TBL] [Abstract][Full Text] [Related]
29. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides.
Mo XY; Cascio P; Lemerise K; Goldberg AL; Rock K
J Immunol; 1999 Dec; 163(11):5851-9. PubMed ID: 10570269
[TBL] [Abstract][Full Text] [Related]
30. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
Bai A; Forman J
J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
[TBL] [Abstract][Full Text] [Related]
31. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein.
Yellen-Shaw AJ; Wherry EJ; Dubois GC; Eisenlohr LC
J Immunol; 1997 Apr; 158(7):3227-34. PubMed ID: 9120278
[TBL] [Abstract][Full Text] [Related]
32. Caspase and proteasome activity during staurosporin-induced apoptosis in lens epithelial cells.
Andersson M; Sjöstrand J; Petersen A; Honarvar AK; Karlsson JO
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2623-32. PubMed ID: 10937575
[TBL] [Abstract][Full Text] [Related]
33. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.
André P; Groettrup M; Klenerman P; de Giuli R; Booth BL; Cerundolo V; Bonneville M; Jotereau F; Zinkernagel RM; Lotteau V
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13120-4. PubMed ID: 9789051
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells.
Dick LR; Cruikshank AA; Destree AT; Grenier L; McCormack TA; Melandri FD; Nunes SL; Palombella VJ; Parent LA; Plamondon L; Stein RL
J Biol Chem; 1997 Jan; 272(1):182-8. PubMed ID: 8995245
[TBL] [Abstract][Full Text] [Related]
35. Lactacystin, proteasome function, and cell fate.
Fenteany G; Schreiber SL
J Biol Chem; 1998 Apr; 273(15):8545-8. PubMed ID: 9535824
[No Abstract] [Full Text] [Related]
36. Need for tripeptidyl-peptidase II in major histocompatibility complex class I viral antigen processing when proteasomes are detrimental.
Guil S; Rodríguez-Castro M; Aguilar F; Villasevil EM; Antón LC; Del Val M
J Biol Chem; 2006 Dec; 281(52):39925-34. PubMed ID: 17088258
[TBL] [Abstract][Full Text] [Related]
37. Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides.
Mo AX; van Lelyveld SF; Craiu A; Rock KL
J Immunol; 2000 Apr; 164(8):4003-10. PubMed ID: 10754291
[TBL] [Abstract][Full Text] [Related]
38. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells.
Imajoh-Ohmi S; Kawaguchi T; Sugiyama S; Tanaka K; Omura S; Kikuchi H
Biochem Biophys Res Commun; 1995 Dec; 217(3):1070-7. PubMed ID: 8554559
[TBL] [Abstract][Full Text] [Related]
39. Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition.
An WG; Hwang SG; Trepel JB; Blagosklonny MV
Leukemia; 2000 Jul; 14(7):1276-83. PubMed ID: 10914553
[TBL] [Abstract][Full Text] [Related]
40. The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit alpha is crucial for their effects on proteasome function including antigen processing.
Huang X; Seifert U; Salzmann U; Henklein P; Preissner R; Henke W; Sijts AJ; Kloetzel PM; Dubiel W
J Mol Biol; 2002 Nov; 323(4):771-82. PubMed ID: 12419264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
